Michael Jones

12PUBLICATIONS
306CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCardiology (incl. cardiovascular diseases)Epigenetics (incl. genome methylation and epigenomics)Epidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Apr 01, 2026
Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Tibor A Zwimpfer, Sian Fereday, Ahwan Pandey

|Oct 03, 2025
Beyond <i>BRCA</i> deficiency: Clinical and molecular predictors of survival in patients with <i>BRCA</i>-deficient tubo-ovarian high-grade serous carcinoma.

Tibor A Zwimpfer, Sian Fereday, Ahwan Pandey

|Jun 05, 2024
Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma.

Flurina A M Saner, Kazuaki Takahashi, Timothy Budden

|Jan 19, 2022
Rare germline copy number variants (CNVs) and breast cancer risk.

Joe Dennis, Jonathan P Tyrer, Logan C Walker

|Nov 05, 2021
Obesity and Breast Cancer Risk in Men: A National Case-Control Study in England and Wales.

Anthony J Swerdlow, Cydney Bruce, Rosie Cooke

Pageof 2